Barclays’s AllianzIM U.S. Equity Buffer10 Aug ETF AUGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.9K Buy
970
+750
+341% +$27.9K ﹤0.01% 4417
2026
Q1
$7.67K Sell
220
-3,338
-94% -$119K ﹤0.01% 4733
2025
Q4
$127K Sell
3,558
-693
-16% -$24.4K ﹤0.01% 4508
2025
Q3
$148K Sell
4,251
-256
-6% -$8.68K ﹤0.01% 4469
2025
Q2
$148K Buy
4,507
+2,861
+174% +$88.1K ﹤0.01% 4452
2025
Q1
$49.8K Buy
+1,646
New +$51.4K ﹤0.01% 4612

Other funds holding AUGT

Barclays's AUGT Position: Q2 2026 in Review

Barclays increased its AllianzIM U.S. Equity Buffer10 Aug ETF (AUGT) stake by 341% in Q2 2026, buying an estimated $27.9K and bringing the position to 970 shares worth $36.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4417.

Barclays first reported a position in AUGT in Q1 2025 and has held it in 6 quarters since. The position peaked at $148K in Q3 2025. 28 funds tracked by Wall St. Rank hold AUGT as of Q2 2026.

  • Barclays held 970 shares of AllianzIM U.S. Equity Buffer10 Aug ETF worth $36.9K as of Q2 2026.
  • Barclays bought 750 AllianzIM U.S. Equity Buffer10 Aug ETF shares in Q2 2026, an estimated $27.9K.
  • AllianzIM U.S. Equity Buffer10 Aug ETF made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4417 holding.
  • Barclays first reported a position in AllianzIM U.S. Equity Buffer10 Aug ETF in Q1 2025 and has held it in 6 quarters since.
  • Barclays's AllianzIM U.S. Equity Buffer10 Aug ETF position peaked at $148K in Q3 2025.
  • 28 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer10 Aug ETF as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.